Nasdaq
$1.65▲ 1.54%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $42.0MShares out 25.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
8- 10.9After-hours26.10.10 05:058-KKey event#●●●#●●●
BioRestorative Therapies, Inc.
BioRestorative Therapies appointed Donald J. Currie as an independent director, effective October 7, 2026. Mr. Currie will serve on the Compensation Committee and the Nominating and Corporate Governance Committee, receiving a monthly cash fee of CAD 2,000.…more
$1.65+1.54%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.11Pre-market26.09.11 22:298-KKey event
BioRestorative Therapies, Inc.
Mr. Silva, Vice President of Research and Development at BioRestorative Therapies, resigned effective September 4, 2026. He claims a 'Good Reason' for resignation due to a change in control, demanding approximately $1.29 million in severance and accelerated equity awards, but the company disputes the validity of his employment agreement and is currently investigating the matter.…more
$1.65+1.54%vs prev closeView filingShare - 9.10After-hours26.09.11 05:308-K/AKey event
BioRestorative Therapies, Inc.
BioRestorative Therapies dismissed its independent auditor, CBIZ CPAs P.C., effective August 28, 2026, and appointed Bush & Associates CPA as its new auditor. The company is currently conducting an independent investigation by its audit committee regarding the suspension of its biocosmeceutical product lines and is reviewing the reliability of its previously issued financial statements.…more
$1.65+1.54%vs prev closeView filingShare
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.2After-hours26.09.03 06:27Bullish#●●●
BioRestorative Therapies Announces 1-for-20 Reverse Stock Split
BioRestorative Therapies is implementing a 1-for-20 reverse stock split to regain compliance with the Nasdaq minimum bid price requirement of $1.00. This action reduces the number of outstanding shares without changing the underlying value of the company.…more
$1.65+1.54%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.2Pre-market26.09.02 19:06
●●●●●●●● ●●●●● ●●●●●●
BioRestorative Therapies announced that interim CEO and CFO Katharyn Field has stepped aside, with Mika Grasso appointed as the new interim CEO. Additionally, Steven Brown will assume the role of Chairman effective September 1, 2026.…more
$1.65+1.54%vs prev closeShareBenzinga
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report